Medication info
Mepiride Tablets (Glyburide)

Mepiride Tablets (Glyburide)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Seoul Pharmaceutical Co., Ltd.
Appearance
Green rectangular tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200202855 · Notified 2002.11.05 · Insurance code 652900460

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This drug is administered orally once daily. Take this drug before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received drug treatment, start with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at 1 ~ 2-week intervals. Generally, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Secondary dose adjustment As diabetes control improves during treatment, the patient's need for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no exact dose equivalence between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is recommended that the method described under Initial dose be followed. That is, start with 1 mg daily and adjust the dose at 1 ~ 2-week intervals. The potency and duration of action of the previous medication should be taken into consideration. 4) Dose adjustment While taking this drug, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by consuming sugar. Hypoglycemia may recur after initial successful management during treatment with sulfonylureas. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this drug with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal. Start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this drug is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia, which may be increased, when this drug is used in combination with metformin. Appropriate caution should be exercised.

Ingredients

Manufacturer
Seoul Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used in conjunction with dietary and exercise therapy to help control blood sugar in patients with type 2 diabetes. It can also be administered alone and can be used when blood sugar control is difficult with oral hypoglycemic agents or insulin. Particularly, it improves blood sugar control when alone or in combination with sulfonylureas or metformin fails. In this way, this medication effectively aids in the blood sugar control of type 2 diabetes, improving the health of patients.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This drug is administered orally once daily. Take this drug before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received drug treatment, start with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at 1 ~ 2-week intervals. Generally, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Secondary dose adjustment As diabetes control improves during treatment, the patient's need for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no exact dose equivalence between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is recommended that the method described under Initial dose be followed. That is, start with 1 mg daily and adjust the dose at 1 ~ 2-week intervals. The potency and duration of action of the previous medication should be taken into consideration. 4) Dose adjustment While taking this drug, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by consuming sugar. Hypoglycemia may recur after initial successful management during treatment with sulfonylureas. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this drug with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal. Start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this drug is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia, which may be increased, when this drug is used in combination with metformin. Appropriate caution should be exercised.

Precautions

This medication should not be administered to patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a comatose state. Patients with a known allergy to this medication, its components, or sulfonylurea medications should also avoid its use. For patients with severely diminished liver or kidney function, it is recommended to switch to insulin treatment instead of using this medication. Pregnant women or those who may become pregnant, as well as nursing mothers, should not take this medication. Patients with severe infections, those undergoing surgery, or those who have suffered major trauma may require insulin treatment, so caution should be exercised when using this medication. Gastrointestinal disorders such as diarrhea or vomiting may lead to improper absorption of food, increasing the risk of hypoglycemia. This medication contains lactose, so patients with genetic disorders such as lactose intolerance, lactose enzyme deficiency, or glucose-galactose malabsorption should not use it. There is a higher risk of hypoglycemia initially after starting treatment, so blood sugar levels should be monitored very carefully, especially in cases of poor nutritional status, skipping meals, or an imbalance in exercise and carbohydrate intake. Patients consuming alcohol, patients with weak kidney or liver function, elderly patients, and those taking other medications are also at increased risk of hypoglycemia, so caution is necessary. Symptoms of hypoglycemia can vary and may include headache, severe hunger, nausea, fatigue, confusion, drowsiness, loss of consciousness, etc.; if such symptoms occur, sugar should be ingested immediately or medical personnel should be notified. During treatment with this medication, regular meals, exercise, and weight management are important, and if blood sugar control is inadequate, consultation with a doctor to adjust treatment methods is necessary. When taking this medication in conjunction with others, be aware of potential interactions, and inform healthcare personnel of all medications being taken and monitor blood sugar regularly. In cases of pregnancy or lactation, it is safer to switch to insulin treatment rather than using this medication. Children and adolescents under 18 should not take this medication, as its safety and efficacy have not been established in this population. In cases of overdose, severe hypoglycemia may occur, necessitating an immediate visit to a healthcare facility for appropriate treatment.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, language abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, cerebral convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, elevated liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, urticaria, rash, respiratory distress, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, flushing of the face, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture, and it is safe to store it at room temperatures between 1 and 30 degrees Celsius. Proper storage will maintain the effectiveness of the medication and prevent deterioration.

Appearance and packaging

Appearance

Green rectangular tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.